Stocks / CNC
CNC stock forecast
CENTENE CORP · Healthcare · Healthcare Plans
The model's rating
Greatly Outperform
CNC is rated Greatly Outperform as of September 29, 2026: its medium-term return forecast is in the top fifth of the stocks the model scores.
Create a free account to compare any two stocks; the numeric score is part of Premium.
In the model portfolio. CNC is holding #3 for 2026 Q3, at 5.4% of the book. See the portfolio
CNC against the S&P 500
| Period | CNC | S&P 500 (SPY) |
|---|---|---|
| 1 month | -3.9% | -0.4% |
| 3 months | -3.1% | +2.6% |
| Year to date | +51.2% | +12.9% |
| 1 year | +76.7% | +16.4% |
Total return, dividends included.
Key numbers
| Price | $62.21 |
| Market cap | 30.73 Billion |
| P/E (trailing 12 months) | -6.0 |
| P/S (trailing 12 months) | 0.1 |
| P/B (latest quarter) | 1.4 |
| Gross margin | 7.8% |
| Net profit margin | -2.5% |
| Return on equity | -24.0% |
| Beta | 0.3 |
As of July 28, 2026.
CNC and its closest peers
| Stock | Company | Market cap | Model rating | |
|---|---|---|---|---|
| HUM | HUMANA INC | 46.46 Billion | Greatly Outperform | HUM vs CNC |
| CI | CIGNA GROUP | 72.73 Billion | Greatly Outperform | CI vs CNC |
| ELV | ELEVANCE HEALTH INC | 85.17 Billion | Outperform | ELV vs CNC |
| CVS | CVS HEALTH CORP | 111.4 Billion | Outperform | |
| UNH | UNITEDHEALTH GROUP INC | 336.54 Billion | Outperform |
Questions
What does the Upfront Investment model say about CNC?
The model rates CENTENE CORP (CNC) "Greatly Outperform" as of September 29, 2026, which means its medium-term return forecast is in the top fifth of the stocks the model scores. The rating is a statistical forecast, not a recommendation to buy or sell.
How is the CNC rating produced?
A machine-learning model forecasts each stock's return over the coming months and ranks the forecasts against each other. The label says where this stock's forecast falls in that ranking. It is refreshed whenever the model's data updates, normally every trading day.
Is CNC in the Upfront Investment model portfolio?
Yes. CNC is holding number 3 in the 2026 Q3 model portfolio, at 5.4% of the book.
The rating is the output of a statistical model and can be wrong. It is not investment advice and takes no account of your circumstances. Past performance does not guarantee future results.